What causes atherosclerotic cardiovascular disease?

It's caused by a combination of genetic and environmental factors that play through three pathways: lipoprotein levels (specifically apob), endothelial health, and inflammation. Damage to the endothelium makes it easier for apob particles to enter the artery wall, leading to oxidation, inflammation, and potential plaque rupture.

How can cardiovascular disease be prevented?

Prevention focuses on reducing apob particles, protecting the endothelium from damage (by not smoking, managing blood pressure, and improving metabolic health), and reducing inflammation through broader lifestyle choices like nutrition, sleep, and exercise. While inflammation is harder to target pharmacologically, the first two factors have clear therapeutic tools.

What are the main drivers of cancer?

While some cancers have clear genetic drivers like BRCA1/2 or Lynch syndrome, many are polygenic. Key environmental triggers include smoking and obesity. Obesity's contribution may be through increased growth factors like insulin and IGF rather than fat itself. A significant component of cancer can also be attributed to accumulated somatic mutations, essentially 'bad luck'.

Why is early and aggressive screening important for cancer prevention?

Given the less effective treatment options for advanced cancer compared to cardiovascular disease, early and aggressive screening is a controversial but important position for increasing the chances of early detection and better outcomes, as treatment success rates for metastatic cancers haven't drastically improved over decades.

How does heart health relate to brain health concerning neurodegenerative diseases?

There's a strong link: 'What's good for the heart is good for the brain.' Interventions that reduce the risk of cardiovascular disease, such as maintaining good metabolic health, lower apob levels, good blood pressure control, and not smoking, also significantly reduce the risk of dementia, including Alzheimer's.

Can neurodegenerative diseases like Alzheimer's be treated effectively?

Unfortunately, for neurodegenerative diseases, especially dementing ones and Parkinson's, there are virtually no viable therapeutic options currently. Therefore, avoiding them by building cognitive and movement reserve through healthy lifestyle choices is the primary priority.

What role do metabolic diseases play in overall health?

Metabolic diseases like fatty liver disease and type 2 diabetes, driven by overnutrition and insulin resistance, are dangerous not only in themselves but also significantly fuel the other three horsemen (cardiovascular disease, cancer, and neurodegenerative diseases), increasing their risk by 25-50%.

The four horsemen of death and how to prevent them

Peter Attia MD

Science & Technology4 min read21 min video

Jul 31, 2024|27,676 views|874|83

Peter Attia MD Dr. Peter Attia Early Medical The Drive Podcast The Drive Longevity Zone 2

Save to Pod

Key Moments

TL;DR

The Four Horsemen of Death (CVD, Cancer, Neurodegenerative Disease, Metabolic Disease) can be managed. Prevention strategies vary, with CVD and Metabolic Disease having clearer paths.

Key Insights

Cardiovascular disease (CVD) is driven by apolipoprotein B (apob), endothelial damage, and inflammation, all of which are largely preventable through lifestyle and targeted therapies.

Cancer prevention has fewer clear targets compared to CVD, with smoking and obesity being significant environmental drivers, but a substantial component may be attributed to random mutations ('bad luck').

Neurodegenerative diseases, like Alzheimer's, share many prevention strategies with CVD ('what's good for the heart is good for the brain'), with exercise being particularly impactful.

Metabolic diseases, particularly insulin resistance, are a primary driver of the other 'horsemen', acting as 'gasoline on the fire' and stem from overnutrition.

While therapeutic options for advanced cancer and neurodegenerative diseases are limited, significant progress has been made in managing and preventing CVD and metabolic disorders.

Early and aggressive screening is emphasized for cancer due to limited effective treatment options for advanced stages.

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) PREVENTION

ASCVD, the first 'horseman', is driven by a combination of genetic and environmental factors, with minimal role for luck. Its pathophysiology involves three key pathways: lipoproteins (specifically apob-carrying ones), the endothelium (the artery lining), and inflammation. To prevent ASCVD, one must reduce apob levels, protect the endothelium from damage (which is aggravated by smoking, high blood pressure, and metabolic dysfunction), and manage inflammation. Data strongly support a direct correlation between lower apob levels and reduced ASCVD risk.

THE ROLE OF APOLIPOPROTEIN B AND ENDOTHELIAL HEALTH

Apolipoprotein B (apob) particles carrying cholesterol can enter the artery wall, especially when the endothelium is damaged. Once inside, oxidation occurs, triggering an inflammatory response. This process can lead to plaque rupture, causing heart attacks. Protecting the endothelium involves avoiding smoking, managing blood pressure, and addressing metabolic conditions like insulin resistance, hyperinsulinemia, and type 2 diabetes. Elevated glucose, insulin, homocystine, and uric acid all contribute to endothelial vulnerability.

INFLAMMATION AS A CONTRIBUTING FACTOR IN ASCVD

While the first two pathways (apob and endothelial health) have clear therapeutic targets, managing inflammation directly is less straightforward. Although some pharmacological agents exist, much of the benefit in reducing inflammation likely comes from broader lifestyle interventions such as nutrition, sleep, and exercise. These upstream factors are critical for overall health and play a significant role in mitigating the inflammatory processes that contribute to ASCVD.

CANCER: GENETICS, ENVIRONMENT, AND THE ROLE OF LUCK

Cancer presents a different challenge. While specific genetic drivers like BRCA1/2 are known for certain cancers, most familial links are polygenic and hard to pinpoint. Significant environmental triggers include smoking and obesity, with obesity's impact likely mediated by growth factors like insulin and IGF-1 rather than excess fat itself. However, a considerable portion of cancer causation is thought to stem from accumulated somatic mutations over time, suggesting a substantial element of 'bad luck'.

CHALLENGES IN CANCER PREVENTION AND TREATMENT

Unlike ASCVD, the playbook for cancer prevention is less robust, and treatment options for advanced (stage 4 or metastatic) cancers remain significantly less effective than for advanced ASCVD. Although survival rates have improved, cure rates have not dramatically increased over the past 50 years. This disparity underscores the critical importance of early and aggressive screening for cancer, despite ongoing debates surrounding its efficacy and risks.

NEURODEGENERATIVE DISEASES AND THE HEART-BRAIN CONNECTION

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, fall somewhere between ASCVD and cancer in terms of understanding and prevention. There's a growing understanding of genetic susceptibility, particularly for Alzheimer's. Crucially, interventions that benefit heart health also benefit brain health ('what's good for the heart is good for the brain'). This includes managing metabolic health, lowering apob and blood pressure, not smoking, and especially exercising.

EXERCISE AND COGNITIVE RESERVE IN NEURODEGENERATION

Exercise appears to have an even greater positive impact on preventing neurodegenerative diseases than on cardiovascular disease, with benefits in both magnitude and confidence. While people may fear dementia greatly, focusing on building cognitive and movement reserve can increase resilience to these conditions. Unfortunately, current therapeutic options for established neurodegenerative diseases are virtually nonexistent, making avoidance the primary strategy. This highlights the importance of proactive prevention and lifestyle choices.

METABOLIC DISEASES AS A FOUNDATIONAL THREAT

Metabolic diseases, driven primarily by overnutrition and resulting energy imbalance, are fundamental to the other 'horsemen'. Insulin resistance, the core issue, leads to downstream effects like fatty liver disease and type 2 diabetes. While harmful in themselves, their greatest danger lies in exacerbating ASCVD, cancer, and neurodegenerative diseases, effectively acting as 'gasoline on the fire' by increasing risk by 25-50%.

Mentioned in This Episode

●Concepts

●People Referenced

Common Questions

The four horsemen are atherosclerotic cardiovascular diseases, cancers, neurodegenerative diseases, and metabolic diseases. Prevention involves managing apob levels, protecting the endothelium, reducing inflammation for cardiovascular health; avoiding smoking and obesity for cancer; maintaining heart health for brain health against neurodegeneration; and addressing overnutrition to prevent metabolic issues.

Topics

Metabolic Diseases Endothelium

Mentioned in this video

conceptoxidation

A chemical process that occurs when apob-wrapped lipoproteins get trapped inside the endothelial layer, leading to inflammation and initiating events that can damage artery walls.

conceptLynch syndrome

A genetic condition heavily associated with an increased risk of colon cancer and other types of cancer.

personBert Vogelstein

A scientist whose work suggests that bad luck, in the form of acquiring somatic mutations, plays a significant role in cancer development.

conceptmetabolic diseases

Primarily a consequence of overnutrition and energy imbalance, leading to insulin resistance, fatty liver disease, and type 2 diabetes, and significantly increasing the risk of other chronic diseases.

conceptblood pressure

Elevated blood pressure weakens the endothelium and is a significant risk factor for cardiovascular disease and dementia.

legislationBRCA2

legislationBRCA1